Zentalis Pharmaceuticals - 53 Year Dividend History | ZNTL

Historical dividend payout and yield for Zentalis Pharmaceuticals (ZNTL) since 1971. The current TTM dividend payout for Zentalis Pharmaceuticals (ZNTL) as of June 18, 2024 is $0.00. The current dividend yield for Zentalis Pharmaceuticals as of June 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.294B $0.000B
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics targeting cancers. The company's lead programs consist of ZN-c5, an oral selective estrogen receptor degrader for estrogen-receptor-positive, HER2-negative breast cancer which is in clinical stage. It operates principally in New York and San Diego. Zentalis Pharmaceuticals, Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio